What is the GES?
With Global Equity Segment, investors are able to trade certain US blue chips and US-listed Asian ADRs during London hours.
Benefits of using the Global Equity Segment
- Trade global equities on the world’s most international exchange
- Trade during a convenient time zone
- Trade and settle in USD
- No stamp duty
Utilising a well-established CREST Depository Interest (CDI) workflow means investors can trade and settle international securities in London quickly, cheaply and efficiently. The ability to move CDIs quickly and easily between markets allows for cross-border execution and settlement within a T+2 settlement cycle. Investors can buy securities in London and sell in New York on the same day during regular trading hours. Both trades would then settle T+2 in respective markets.
Explore
Find out about companies we have welcomed to our markets
London Stock Exchange welcomes J.P. Morgan Asset Management to celebrate its new sustainable ETF
Today the London Stock Exchange markets were opened by J.P. Morgan Asset Management (JPMAM) to celebrate the launch of JPMorgan Carbon Transition Global Equity UCITS ETF (ticker: JPCT), a sustainable ETF which offers core exposure to global equities with a low tracking error, compared to the MSCI World Index, and have a meaningful reduction in carbon intensity.
JPCT will track the JPM
London Stock Exchange welcomes Barclays Celebrating its Green Bond issuance
Sasha Wiggins, Group Head of Public Policy and Corporate Responsibility at Barclays this morning opened the market at London Stock Exchange in recognition of the listing of the bank’s second Green Bond. The bond was listed on Tuesday 3 November, raising £400m to support the development of Barclays’ Green Mortgages portfolio.
Commenting on the Green Bond issuance Sasha Wiggins, Group H
London Stock Exchange Welcomes Verici Dx plc to AIM
London Stock Exchange welcomes Verici Dx plc (‘Verici Dx’ or the ‘Company’), a developer of advanced clinical diagnostics for organ transplant, to celebrate the listing of the Company's public shares onto AIM, under the ticker "VRCI".
Verici Dx is an immuno-diagnostics development company, initially focused on the kidney transplantation market. The Company's kidney transplant
London Stock Exchange welcomes SourceBio International plc to AIM
London Stock Exchange today welcomes SourceBio International plc (‘SourceBio’ or the ‘Company’), a leading international provider of integrated state-of-the-art laboratory services and products, to celebrate the listing of the Company's public shares onto AIM, under the ticker "SBI".
SourceBio, employs approximately 235 employees across six sites globally, in the UK, Ireland and the U